Amgen Inc. (AMGN) Capital expenditures 2016–2025
Amgen Inc. (AMGN) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$1.9BFY2025 · since FY2016: $738.0M → $1.9B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.9B | +69.5% |
| FY2024 | $1.1B | -1.4% |
| FY2023 | $1.1B | +18.8% |
| FY2022 | $936.0M | +6.4% |
| FY2021 | $880.0M | +44.7% |
| FY2020 | $608.0M | -1.6% |
| FY2019 | $618.0M | -16.3% |
| FY2018 | $738.0M | +11.1% |
| FY2017 | $664.0M | -10.0% |
| FY2016 | $738.0M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice